PatientsVille.com Logo

PatientsVille

Aggrenox Side Effects

Common Aggrenox Side Effects


The most commonly reported Aggrenox side effects (click to view or check a box to report):

Headache (183)
Nausea (79)
Cerebrovascular Accident (73)
Vomiting (55)
Dizziness (49)
Transient Ischaemic Attack (48)
Diarrhoea (37)
Fatigue (28)
Cerebral Haemorrhage (27)
Pain In Extremity (25)
Asthenia (20)
Loss Of Consciousness (20)
Dyspnoea (20)
Fall (18)
Anaemia (18)
Chest Pain (16)
Feeling Abnormal (16)
Gastrointestinal Haemorrhage (15)
Blood Pressure Increased (15)
Death (15)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Aggrenox Side Effects Reported to FDA

The following Aggrenox reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Aggrenox on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Spinal Fracture, Fall
This is a report of a 73-year-old male patient (weight: NA) from US, suffering from the following symptoms/conditions: cerebrovascular accident prophylaxis,hypertension, who was treated with Aggrenox (dosage: Dose Per Application: 25 Mg/200 Mg; Daily Dose: 25mg/200mg, start time: 2011), combined with:
  • Labetalol (1200 Mg)
  • Tamsulosin (0.4 Mg)
  • Docusate Sodium (100 Mg)
  • Lisinopril (5 Mg)
  • Spironolactone (25 Mg)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Spinal Fracture
  • Fall
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Aggrenox treatment in male patients, resulting in spinal fracture side effect. The patient was hospitalized.

Feeling Abnormal, Headache, Confusional State, Memory Impairment
This report suggests a potential Aggrenox Feeling Abnormal, Headache, Confusional State, Memory Impairment side effect(s) that can have serious consequences. A female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: cerebrovascular accident prophylaxis,blood cholesterol increased and used Aggrenox (dosage: Strength: 25 Mg / 200 Mg; Daily Dose: 50 Mg/ 400 Mg) starting 201308. Soon after starting Aggrenox the patient began experiencing various side effects, including:
  • Feeling Abnormal
  • Headache
  • Confusional State
  • Memory Impairment
Drugs used concurrently:
  • Simvastatin (20 Mg)
Although Aggrenox demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as feeling abnormal, may still occur.

Dizziness, Vertigo, Fall
This Dizziness, Vertigo, Fall problem was reported by a consumer or non-health professional from US. A 77-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: prophylaxis,nasal congestion,transient ischaemic attack. On Feb 10, 2014 this consumer started treatment with Aggrenox (dosage: Strength: 25 Mg / 200 Mg; Daily Dose: 50 Mg / 400 Mg). The following drugs were being taken at the same time:
  • Saline Nasal Spray (2 Puf)
  • Aspirin (81 Mg)
  • Asthmanex (2 Puf)
When commencing Aggrenox, the patient experienced the following unwanted symptoms/side effects:
  • Dizziness
  • Vertigo
  • Fall
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as dizziness, may become evident only after a product is in use by the general population.

Crying, Diarrhoea, Nausea, Headache
This is a report of a 91-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: cerebrovascular accident prophylaxis and was treated with Aggrenox (dosage: Strength: 25 Mg / 200 Mg; Daily Dose: 25 Mg/200 Mg) starting Jan 07, 2014. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Crying
  • Diarrhoea
  • Nausea
  • Headache
This opens a possibility that Aggrenox treatment could cause the above reactions, including crying, and some female subjects may be more susceptible.



A 78-year-old female patient (weight: NA) from US with the following symptoms/conditions: NA started Aggrenox treatment (dosage: Strength: 25 Mg / 200 Mg; Daily Dose: 50 Mg / 400 Mg) on Oct 24, 2013. Soon after starting Aggrenox treatment, the subject experienced various side effects, including:
    Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Aggrenox.

    Dyspnoea, Loss Of Consciousness, Asthenia, Blood Sodium Decreased
    A 61-year-old female patient from US (weight: NA) experienced symptoms, such as: cerebrovascular accident prophylaxis and was treated with Aggrenox(dosage: NA). The treatment was initiated on 201310. After that a consumer reported the following side effect(s):
    • Dyspnoea
    • Loss Of Consciousness
    • Asthenia
    • Blood Sodium Decreased
    Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Aggrenox efficacy:
    • Aspirin (81 Mg)
    • Gabapentin (600 Mg)
    • Lisinopril (10 Mg)
    • Metoprolol (75 Mg)
    • Nitroglycerin (0.4 Mg)
    • Pravastatin (40 Mg)
    • Xanax (3 Mg)
    The patient was hospitalized.

    Invasive Ductal Breast Carcinoma
    In this report, Aggrenox was administered for the following condition: cerebrovascular accident prophylaxis,pain,arthralgia,hypertension,blood cholesterol increased,gastrooesophageal reflux disease,neuralgia.A 66-year-old female consumer from US (weight: NA) started Aggrenox treatment (dosage: Strength: 25mg/200mg; Daily Dose: 50mg/200mg) on 2001.Sometime after starting the treatment, the patient complained of the following side effect(s):
    • Invasive Ductal Breast Carcinoma
    A possible interaction with other drugs could have contributed to this reaction:
    • Fentanyl (16.6667 Mcg)
    • Diclofenac (75 Mg)
    • Enalaparil (20 Mg)
    • Atorvastatin (80 Mg)
    • Lansoprazole (30 Mg)
    • Duloxetine (120 Mg)
    • Duloxetine
    The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Aggrenox treatment could be related to the listed above side effect(s).

    Asthenia, Product Quality Issue
    This is a report of the following Aggrenox side effect(s):
    • Asthenia
    • Product Quality Issue
    A 76-year-old female patient from US (weight: NA) presented with the following condition: cerebrovascular accident prophylaxis and received a treatment with Aggrenox (dosage: Dose Per Application: 25 Mg / 200 Mg; Daily Dose: 50 Mg/400 Mg) starting: 2006.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Aggrenox treatment could be associated with the listed above side effect(s).

    Headache, Abdominal Discomfort
    This Aggrenox report was submitted by a 55-year-old male consumer from US (weight: NA). The patient was diagnosed with: ischaemic heart disease prophylaxis,hypertension,fluid retention,blood cholesterol increased and Aggrenox was administered (dosage: Strength: 25 Mg / 200 Mg; Daily Dose: 50 Mg/400mg) starting: 2004. The consumer developed a set of symptoms:
    • Headache
    • Abdominal Discomfort
    Other drugs used simultaneously:
    • Coversyl
    • Pms-indapamide
    • Rosuvastatin
    Those unexpected symptoms could be linked to a Aggrenox treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

    Mobility Decreased
    This is a report of a possible correlation between Aggrenox use and the following symptoms/side effect(s):
    • Mobility Decreased
    which could contribute to an assessment of Aggrenox risk profile.A female consumer from US (weight: NA) was suffering from cerebrovascular accident prophylaxis and was treated with Aggrenox (dosage: Dose Per Application: 25 Mg/200mg; Daily Dose:50mg/400mg) starting NS.Other concurrent medications: NA.

    Hyperparathyroidism, Blood Calcium Increased
    A 76-year-old female patient from US (weight: NA) presented with the following symptoms: cerebrovascular accident prophylaxis and after a treatment with Aggrenox (dosage: Strength: 25 Mg / 200 Mg; Daily Dose: 25mg/200 Mg) experienced the following side effect(s):
    • Hyperparathyroidism
    • Blood Calcium Increased
    The treatment was started on 2006. Aggrenox was used in combination with the following drugs: NA.This report could alert potential Aggrenox consumers.

    Gastrointestinal Haemorrhage, Anaemia, Platelet Count Abnormal
    In this report, a male patient from US (weight: NA) was affected by a possible Aggrenox side effect.The patient was diagnosed with NA. After a treatment with Aggrenox (dosage: 2 Anz, start date: 2008), the patient experienced the following side effect(s):
    • Gastrointestinal Haemorrhage
    • Anaemia
    • Platelet Count Abnormal
    The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Aggrenox treatment.

    Bronchitis, Decreased Appetite, Epistaxis
    This is a report of a 56-year-old female patient from US (weight: NA), who used Aggrenox (dosage: D:25/200mg, Dd:50/400mg) for a treatment of cerebrovascular accident prophylaxis. After starting a treatment on 201109, the patient experienced the following side effect(s):
    • Bronchitis
    • Decreased Appetite
    • Epistaxis
    The following drugs could possibly have interacted with the Aggrenox treatment NA.The patient was hospitalized.Taken together, these observations suggest that a Aggrenox treatment could be related to side effect(s), such as Bronchitis, Decreased Appetite, Epistaxis.

    Coeliac Disease
    This coeliac disease side effect was reported by a consumer or non-health professional from US. A 71-year-old female patient (weight:NA) experienced the following symptoms/conditions: cerebrovascular accident prophylaxis,diarrhoea. The patient was prescribed Aggrenox (dosage: Strength: 25 Mg / 200 Mg; Daily Dose: 50mg/400mg), which was started on 2000. Concurrently used drugs:
    • Immodium Ad
    When starting to take Aggrenox the consumer reported the following symptoms:
    • Coeliac Disease
    These side effects may potentially be related to Aggrenox.

    Nasopharyngitis, Off Label Use
    This is a Aggrenox side effect report of a 76-year-old female patient (weight:NA) from US, suffering from the following symptoms/conditions: headache, who was treated with Aggrenox (dosage:Dose Per Application: 25 Mg / 200 Mg; 50 Mg / 400 Mg, start time: 2004), combined with: NA., and developed a serious reaction and a nasopharyngitis side effect. The patient presented with:
    • Nasopharyngitis
    • Off Label Use
    which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Aggrenox treatment in female patients suffering from headache, resulting in nasopharyngitis.

    Muscle Spasms
    This report suggests a potential Aggrenox muscle spasms side effect(s) that can have serious consequences. A 72-year-old female patient from US (weight:NA) was diagnosed with the following health condition(s): prophylaxis and used Aggrenox (dosage: Strength: 25 Mg / 200 Mg; Daily Dose: 50mg/400 Mg) starting Jan 06, 2014. Soon after starting Aggrenox the patient began experiencing various side effects, including:
    • Muscle Spasms
    Drugs used concurrently:NA. Although Aggrenox demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as muscle spasms, may still occur.

    Cardiac Failure Congestive
    This cardiac failure congestive problem was reported by a consumer or non-health professional from US. A 74-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): NA.On 201401 a consumer started treatment with Aggrenox (dosage: Dose Per Application: 25/200mg; Daily Dose: 50/400mg). The following drugs/medications were being taken at the same time: NA. When commencing Aggrenox, the patient experienced the following unwanted symptoms /side effects:
    • Cardiac Failure Congestive
    The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as cardiac failure congestive, may become evident only after a product is in use by the general population.

    Cerebrovascular Accident
    This is a Aggrenox side effect report of a female patient (weight: NA) from US. The patient developed the following symptoms/conditions: cerebrovascular accident prophylaxis and was treated with Aggrenox (dosage: Strength: 25 Mg / 200 Mg; Daily Dose: 50mg/400mcg) starting 2007. Concurrently used drugs:
    • Omeprazole
    • Simvastatin
    • Zetia
    • Tramadol
    • Vitamin D
    • Propafenone
    • Synthroid
    • Multivitamin
    Soon after that, the consumer experienced the following of symptoms:
    • Cerebrovascular Accident
    This opens a possibility that Aggrenox could cause cerebrovascular accident and that some female patients may be more susceptible.

    Diabetic Foot, Lethargy, Heart Rate Decreased, Implant Site Infection, Blood Potassium Increased, Blood Creatinine Increased, Thyroid Neoplasm, Scrotal Swelling
    A 66-year-old male patient (weight: NA) from US with the following symptoms: cerebrovascular accident prophylaxis,hypertension,hypothyroidism,blood cholesterol increased started Aggrenox treatment (dosage: Strength: 25 Mg / 200 Mg; Daily Dose: 50 Mg/ 400 Mg) on 201210. Soon after starting Aggrenox treatment, the consumer experienced several side effects, including:
    • Diabetic Foot
    • Lethargy
    • Heart Rate Decreased
    • Implant Site Infection
    • Blood Potassium Increased
    • Blood Creatinine Increased
    • Thyroid Neoplasm
    • Scrotal Swelling
    . Concurrently used drugs:
    • Cilostazol (100 Mg)
    • Levothyroxine (175 Mcg)
    • Crestor (10 Mg)
    • Levothyronine (5 Mcg)
    • Gabapentin (Formulation: Caplet)
    • Amlodipine (5 Mg)
    • Furosemide (20 Mg)
    • Lantus Insulin (Formulation:subcutaneous)
    The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Aggrenox side effects, such as diabetic foot.

    Multi-organ Failure, Renal Disorder, Lung Disorder, Pulmonary Oedema, Lung Infection
    This multi-organ failure side effect was reported by a consumer or non-health professional from US. A 72-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Aggrenox (dosage: Strength: 25 Mg / 200 Mg; Daily Dose: 50mg/400mg), which was started on 200902. Concurrently used drugs: NA..When starting to take Aggrenox the consumer reported symptoms, such as:
    • Multi-organ Failure
    • Renal Disorder
    • Lung Disorder
    • Pulmonary Oedema
    • Lung Infection
    These side effects may potentially be related to Aggrenox. The patient was hospitalized.

    Wrist Fracture, Fall, Agitation, Rash, Skin Irritation
    This is a report of a 76-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: cerebrovascular accident prophylaxis,arthritis,seasonal allergy,hypothyroidism, who was treated with Aggrenox (dosage: NA, start time: 2011), combined with:
    • Meloxicam (15 Mg)
    • Loratadine
    • Levothyroxine (112 Mg)
    and developed a serious reaction and side effect(s). The consumer presented with:
    • Wrist Fracture
    • Fall
    • Agitation
    • Rash
    • Skin Irritation
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Aggrenox treatment in female patients, resulting in wrist fracture side effect. The patient was hospitalized.

    Cerebrovascular Accident, Pneumonia
    This report suggests a potential Aggrenox Cerebrovascular Accident, Pneumonia side effect(s) that can have serious consequences. A 60-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: cerebrovascular accident prophylaxis and used Aggrenox (dosage: Strength: 25 Mg / 200 Mg; Daily Dose: 50 Mg/ 400 Mg) starting 2011. Soon after starting Aggrenox the patient began experiencing various side effects, including:
    • Cerebrovascular Accident
    • Pneumonia
    Drugs used concurrently: NA.The patient was hospitalized. Although Aggrenox demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as cerebrovascular accident, may still occur.

    Pneumonia
    This Pneumonia problem was reported by a consumer or non-health professional from US. A 63-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: cerebrovascular accident prophylaxis,depression,fluid retention. On 201107 this consumer started treatment with Aggrenox (dosage: Strength: 25 Mg / 200 Mg; Daily Dose: 50 Mg/400 Mg). The following drugs were being taken at the same time:
    • Citalopram (10 Mg)
    • Furosemide (40 Mg)
    • Pravastatin (60 Mg)
    • Norvasc (5 Mg)
    When commencing Aggrenox, the patient experienced the following unwanted symptoms/side effects:
    • Pneumonia
    The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as pneumonia, may become evident only after a product is in use by the general population.

    Failure To Thrive, Infarction, Urinary Tract Infection, Convulsion, Renal Failure Acute, Renal Failure Chronic
    This is a report of a 81-year-old male patient (weight: NA) from US. The patient developed the following symptoms/conditions: cerebrovascular accident prophylaxis,cardiac operation and was treated with Aggrenox (dosage: NA) starting Jan 18, 2013. Concurrently used drugs:
    • Atenolol (25 Mg)
    • Simvastatin (10 Mg)
    • Donepezil (10 Mg)
    Soon after that, the consumer experienced the following side effects:
    • Failure To Thrive
    • Infarction
    • Urinary Tract Infection
    • Convulsion
    • Renal Failure Acute
    • Renal Failure Chronic
    The patient was hospitalized. This opens a possibility that Aggrenox treatment could cause the above reactions, including failure to thrive, and some male subjects may be more susceptible.

    Aortic Valve Disease, Contusion, Hot Flush
    A 89-year-old female patient (weight: NA) from US with the following symptoms/conditions: cerebrovascular accident prophylaxis started Aggrenox treatment (dosage: NA) on 201307. Soon after starting Aggrenox treatment, the subject experienced various side effects, including:
    • Aortic Valve Disease
    • Contusion
    • Hot Flush
    Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Aggrenox.

    1 of 37 



    Top 10 Aggrenox Side Effects for Women

    Women Side EffectsReports
    Headache 106
    Nausea 60
    Cerebrovascular Accident 44
    Dizziness 34
    Vomiting 34
    Transient Ischaemic Attack 28
    Diarrhoea 23
    Fatigue 18
    Dyspnoea 17
    Pain In Extremity 16

    Top 10 Aggrenox Side Effects for Men

    Men Side EffectsReports
    Headache 77
    Cerebrovascular Accident 29
    Vomiting 21
    Transient Ischaemic Attack 20
    Nausea 19
    Cerebral Haemorrhage 16
    Dizziness 15
    Diarrhoea 14
    Anaemia 13
    Renal Failure 13

    Keep Track of Side Effects

    Note Your Observations

    It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

    Why Your Notes are Important

    Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Aggrenox Side Effects

    Did You Have a Aggrenox Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Aggrenox for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Aggrenox Safety Alerts, Active Ingredients, Usage Information

    NDC0597-0001
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameAggrenox
    Nameaspirin and dipyridamole
    Dosage FormCAPSULE
    RouteORAL
    On market since19991219
    LabelerBoehringer Ingelheim Pharmaceuticals, Inc.
    Active Ingredient(s)ASPIRIN; DIPYRIDAMOLE
    Strength(s)25; 200
    Unit(s)mg/1; mg/1
    Pharma ClassCyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammato

    Aggrenox Dosage, Warnings, Usage.

    Side Effects reported to FDA: 908

    Aggrenox safety alerts: No

    Reported deaths: 69

    Reported hospitalizations: 426

    Latest Aggrenox clinical trials